scholarly article | Q13442814 |
P2093 | author name string | A H Sharpe | |
E Y Snyder | |||
W P Lynch | |||
P2860 | cites work | F4/80, a monoclonal antibody directed specifically against the mouse macrophage | Q28281328 |
Multipotent neural cell lines can engraft and participate in development of mouse cerebellum | Q28290006 | ||
Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes | Q33634507 | ||
Three laboratory strains of spleen focus-forming virus: comparison of their genomes and translational products | Q33911777 | ||
Turnover of resident microglia in the normal adult mouse brain | Q34435397 | ||
Cell therapy | Q34467385 | ||
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer | Q34585324 | ||
Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain | Q34693537 | ||
Antigen markers of macrophage differentiation in murine tissues | Q35483485 | ||
Murine retroviral neurovirulence correlates with an enhanced ability ofvirus to infect selectively, replicate in, and activate resident microglial cells | Q35831029 | ||
Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. | Q35833692 | ||
Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain | Q35852738 | ||
Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains | Q35874088 | ||
Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus | Q36303669 | ||
Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex | Q36605438 | ||
Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles. | Q36633809 | ||
Murine retrovirus-induced spongiform encephalopathy: disease expression is dependent on postnatal development of the central nervous system | Q36645249 | ||
Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication | Q36688988 | ||
Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period | Q36697814 | ||
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses | Q36796266 | ||
Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus | Q36803647 | ||
Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production | Q36811075 | ||
Monoclonal antibodies specific for wild mouse neurotropic retrovirus: detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease. | Q36855027 | ||
Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene | Q36886039 | ||
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region | Q36887904 | ||
A 1.6-kilobase-pair fragment in the genome of the ts1 mutant of Moloney murine leukemia virus TB that is associated with temperature sensitivity, nonprocessing of Pr80env, and paralytogenesis | Q36901062 | ||
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production | Q36918698 | ||
Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens | Q39510598 | ||
Mac-1: a macrophage differentiation antigen identified by monoclonal antibody | Q39557974 | ||
Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus | Q40047960 | ||
Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus | Q40134247 | ||
Microglial secretion products and their impact on the nervous system. | Q40868888 | ||
Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease | Q40870408 | ||
Microglia in degenerative neurological disease. | Q40870414 | ||
The origin and nature of ramified and amoeboid microglia: a historical review and current concepts | Q40870421 | ||
The use of nonneuronal cells for gene delivery | Q40911146 | ||
Physiological relevance and functional potential of central nervous system-derived cell lines | Q41056483 | ||
Stem cells in the central nervous system | Q41116811 | ||
Human immunodeficiency virus and the brain | Q41132570 | ||
Is there a neural stem cell in the mammalian forebrain? | Q41169054 | ||
Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells | Q41212883 | ||
Neural stem cells are blasting off. | Q41331504 | ||
Regulatory mechanisms in stem cell biology | Q41352398 | ||
Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain | Q41358776 | ||
Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras | Q41625499 | ||
Immortalized neural progenitor cells for CNS gene transfer and repair. | Q41639955 | ||
Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer | Q41741592 | ||
Murine retroviral-induced spongiform neuronal degeneration parallels resident microglial cell infection: ultrastructural findings | Q44948349 | ||
Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features | Q45075576 | ||
Development of pathological lesions in the central nervous system of transgenic mice expressing the env gene of ts1 Moloney murine leukemia virus in the absence of the viral gag and pol genes and viral replication. | Q45760658 | ||
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice | Q45819246 | ||
Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation | Q45872830 | ||
Gene therapy -- promises, problems and prospects | Q45883584 | ||
Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus. | Q48125534 | ||
Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. | Q48617389 | ||
Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease | Q48668986 | ||
Central nervous system cell transplantation: a novel therapy for storage diseases? | Q49023545 | ||
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment | Q49050987 | ||
Dissecting the determinants of neuropathogenesis of the murine oncornaviruses | Q77097346 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurodegeneration | Q1755122 |
neural stem cell | Q2944097 | ||
microglia | Q1622829 | ||
P304 | page(s) | 6841-6851 | |
P577 | publication date | 1999-08-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration | |
P478 | volume | 73 |
Q37483966 | Applications of neural and mesenchymal stem cells in the treatment of gliomas |
Q36694004 | Ecotropic Murine Leukemia Virus Infection of Glial Progenitors Interferes with Oligodendrocyte Differentiation: Implications for Neurovirulence |
Q34666321 | Gene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesis |
Q35217437 | Identification of a neuronal gene expression signature: role of cell cycle arrest in murine neuronal differentiation in vitro |
Q34385134 | Implications and limitations of cellular reprogramming for psychiatric drug development |
Q34192523 | MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis |
Q39635226 | Misfolding of CasBrE SU is reversed by interactions with 4070A Env: implications for gammaretroviral neuropathogenesis |
Q35827956 | Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas |
Q30405825 | Postinhibitory rebound neurons and networks are disrupted in retrovirus-induced spongiform neurodegeneration |
Q40095203 | Rebound from Inhibition: Self-Correction against Neurodegeneration? |
Q34741927 | Retrovirus-induced spongiform neurodegeneration is mediated by unique central nervous system viral targeting and expression of env alone |
Q34153594 | Targeting β-secretase with RNAi in neural stem cells for Alzheimer's disease therapy |
Q89553658 | The evolution of stem cells, disease modeling, and drug discovery for neurological disorders |
Q37036721 | Unique N-linked glycosylation of CasBrE Env influences its stability, processing, and viral infectivity but not its neurotoxicity |
Search more.